Mankind Pharma Ltd. is proposing an Initial Public Offering (IPO) on the NSE & BSE platform under the Mainboard category.
Subscription opens 25 Apr 2023, closes 27 Apr 2023. Listing expected 05 May 2023. Apply via ASBA or UPI.
Mankind Pharma Ltd. proposes to utilise the net proceeds from the Issue for the following objects:
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 13 | ₹14,040 |
| Retail (Max) | 13 | 169 | ₹182,520 |
| sNII (Min) | 15 | 195 | ₹210,600 |
| bNII (Min) | 72 | 936 | ₹1,010,880 |
| Particulars | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Revenue from Operations | N/A | N/A | N/A |
| EBITDA | N/A | N/A | N/A |
| Profit After Tax (PAT) | N/A | N/A | N/A |
| Net Worth | N/A | N/A | N/A |
| Total Assets | N/A | N/A | N/A |
| Reserves & Surplus | N/A | N/A | N/A |
| Total Borrowings | N/A | N/A | N/A |